Rational Design of Schiff Base Copper Chelators as Potent Necroptosis Inducers for Anticancer Therapy

Area of Science:

• Medicinal Chemistry
• Oncology
• Biochemistry

Background:

• Cancer cells exhibit a dependency on copper for critical processes like proliferation and survival.
• Existing copper chelators face challenges with specificity and efficacy.
• Schiff bases offer a tunable and specific platform for developing advanced copper chelators.

Purpose of the Study:

• To rationally design, synthesize, and evaluate novel Schiff base copper chelators.
• To enhance cellular uptake and mitochondrial damage through structural modifications.
• To identify a potent and non-toxic anticancer agent.

Main Methods:

• Rational design and synthesis of Schiff base derivatives.
• Structural modifications including aromatic system expansion and triphenylphosphonium (TPP) incorporation.
• Evaluation of cellular uptake, mitochondrial damage, and in vivo tumor suppression.

Main Results:

• The novel Schiff base chelator, compound 2d, was synthesized and characterized.
• Compound 2d effectively depletes copper, disrupting redox homeostasis.
• This leads to reactive oxygen species (ROS)-mediated mitochondrial damage, necroptosis, and potent, non-toxic tumor suppression in vivo.

Conclusions:

• Schiff base modification is an effective strategy for optimizing copper chelators.
• Compound 2d demonstrates significant potential as an anticancer therapeutic by targeting copper addiction.
• The study provides a promising candidate for further development in cancer treatment.